GULYAKIN, I. et al. 2021. FEATURES OF THE DEVELOPMENT OF A LYOPHILIZED INJECTABLE DOSAGE FORM OF THE ORIGINAL ANTICANCER DRUG LCS-1208. International Journal of Applied Pharmaceutics. 13, 4 (Jul. 2021), 102–105. DOI:https://doi.org/10.22159/ijap.2021v13i4.41371.